Fri, March 5, 2021
Thu, March 4, 2021
Wed, March 3, 2021
Tue, March 2, 2021
Mon, March 1, 2021
Fri, February 26, 2021
Thu, February 25, 2021
Wed, February 24, 2021

Vikram Purohit Maintained (TBPH) at Buy with Decreased Target to $30 on, Mar 1st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-30-on-mar-1st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $31 to $30 on, Mar 1st, 2021.

Vikram has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram


  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $41 on, Wednesday, February 24th, 2021
  • Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $30 on, Tuesday, November 24th, 2020

Publication Contributing Sources